Clinical Activity, Tolerability, and Long-Term Follow-Up of Durvalumab in Patients With Advanced NSCLC
Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2019.06.010
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2019
Authors
Publisher
Elsevier BV